Accès libre

Tauopathies: A Distinct Class of Neurodegenerative Diseases

 et    | 30 mai 2008
À propos de cet article

Citez

Hasegawa M, Smith MJ, Goedert M. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly. FEBS Lett 1998; 437(3): 207-210.10.1016/S0014-5793(98)01217-4Search in Google Scholar

Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X, Wiederholt W, Hansen L, Masliah E, Thal LJ, Katzman R, Xia Y, Saitoh T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 1997; 41(2): 277-281.10.1002/ana.410410222Search in Google Scholar

Oliva R, Tolosa E, Ezquerra M, Molinuevo JL, Valldeoriola F, Burguera J, Calopa M, Villa M, Ballesta F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch Neurol 1998; 55(8): 1122-1124.10.1001/archneur.55.8.1122Search in Google Scholar

Bennett P, Bonifati V, Bonuccelli U, Colosimo C, de Mari M, Fabbrini G, Marconi R, Meco, G, Nicholl DJ, Stocchi F, Vanacore N, Vieregge P, Williams AC. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. Neurology 1998; 51(4): 982-985.10.1212/WNL.51.4.982Search in Google Scholar

Morris HR, Janssen JC, Bandmann O, Daniel SR, Rossor, MN, Lees AJ, Wood NW. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases. J Neurol Neurosurg Psychiatry 1999; 66(5): 665-667.10.1136/jnnp.66.5.665Search in Google Scholar

Higgins JJ, Golbe LI, de Biase A, Jankovic J, Factor SA, Adler RL. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy. Neurology 2000; 55(9): 1364-1367.10.1212/WNL.55.9.1364Search in Google Scholar

Hoenicka J, Perez M, Perez-Tur J, Barabash A, Godoy M, Vidal L, Astarloa R, Avila J, Nygaard T, de Yebenes JG. The tau gene A0 allele and progressive supranuclear palsy. Neurology 1999; 1(2): 1219-1225.10.1212/WNL.53.6.1219Search in Google Scholar

Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J, Hardy J, Lynch T, Bigio E, Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999; 8(4): 711-715.10.1093/hmg/8.4.711Search in Google Scholar

Morris HR, Khan MN, Janssen JC, Brown JM, Perez-Tur J, Baker M, Ozansoy M, Hardy J, Hutton M, Wood NW, Lees AJ, Revesz T, Lantos P, Rossor MN. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 2001; 58(11): 1813-1816.10.1001/archneur.58.11.1813Search in Google Scholar

Houlden H, Baker M, Adamson J, Grover A, Waring S, Dickson D, Lynch T, Boeve B, Petersen RC, Pickering-Brown S, Owen F, Neary D, Craufurd D, Snowden J, Mann D, Hutton M. Frequency of tau mutations in three series of non-Alzheimer's degenerative dementia. Ann Neurol 1999; 46(2): 243-248.10.1002/1531-8249(199908)46:2<243::AID-ANA14>3.0.CO;2-LSearch in Google Scholar

Houlden H, Baker M, Morris HR, MacDonald N, Pickering-Brown S, Adamson J, Lees AJ, Rossor MN, Quinn NP, Kertesz A, Khan MN, Hardy J, Lantos PL, George-Hyslop P, Munoz DG, Mann D, Lang AE, Bergeron C, Bigio EH, Litvan I, Bhatia KP, Dickson D, Wood NW, Hutton M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001; 56(12): 1702-1706.10.1212/WNL.56.12.1702Search in Google Scholar

Conrad C, Vianna C, Freeman M, Davies P. Saitohin, a novel putative gene in the tau locus. Proc Natl Acad Sci USA 2002; 99(11): 7751-7756.10.1073/pnas.112194599Search in Google Scholar

de Silva R, Hope A, Pittman A, Weale ME, Morris HR, Wood NW, Lees AJ. Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy. Neurology 2003; 61(3): 407-409.10.1212/01.WNL.0000073140.25533.90Search in Google Scholar

Russ C, Lovestone S, Baker M, Pickering-Brown SM, Andersen PM, Furlong R, Mann D, Powell JF. The extended haplotype of the microtubule associated protein tau gene is not associated with Pick's disease. Neurosci Lett 2001; 299(1-2): 156-158.10.1016/S0304-3940(00)01785-7Search in Google Scholar

Morris HR, Baker M, Yasojima K, Houlden H, Khan MN, Wood NW, Hardy J, Grossman M, Trojanowski J, Revesz T, Bigio EH, Bergeron C, Janssen JC, McGeer PL, Rossor MN, Lees AJ, Lantos PL, Hutton M. Analysis of tau haplotypes in Pick's disease. Neurology 2002; 59(3): 443-445.10.1212/WNL.59.3.443Search in Google Scholar

Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 1994; 369(6480): 488-491.10.1038/369488a0Search in Google Scholar

Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 2001; 114(6): 1179-1187.10.1242/jcs.114.6.1179Search in Google Scholar

Haltiwanger RS, Busby S, Grove K, Li S, Mason D, Medina L, Moloney D, Philipsberg G, Scartozzi R. O-glycosylation of nuclear and cytoplasmic proteins: regulation analogous to phosphorylation?. Biochem Biophys Res Commun 1997; 231(2): 237-242.10.1006/bbrc.1997.6110Search in Google Scholar

Kreppel LK, Blomberg MA, Hart GW. Dynamic glycosylation of nuclear and cytosolic proteins. J Biol Chem 1997; 272(14): 9308-9315.10.1074/jbc.272.14.9308Search in Google Scholar

Kamemura K, Hart GW. Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription. Prog Nucleic Acid Res Mol Biol 2003; 73: 107-136.10.1016/S0079-6603(03)01004-3Search in Google Scholar

Dong DL, Xu ZS, Hart GW, Cleveland DW. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H. J Biol Chem 1996; 271(34): 20845-20852.10.1074/jbc.271.34.20845Search in Google Scholar

Lovestone S, Reynolds CH. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997; 78(2): 309-324.Search in Google Scholar

Seubert P, Mawal-Dewan M, Barbour R, Jakes R, Goedert M, Johnson GV, Litersky JM, Schenk D, Lieberburg L, Trojanowski JQ. Detection of phosphorylated Ser262 in fetal tau, adult tau and paired helical filament tau. J Biol Chem 1995; 270(32): 18917-18922.10.1074/jbc.270.32.18917Search in Google Scholar

Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 1997; 409(1): 57-62.10.1016/S0014-5793(97)00483-3Search in Google Scholar

Hayashi S, Toyoshima Y, Hasegawa M, Umeda Y, Wakabayashi K, Tokiguchi S, Iwatsubo T, Takahashi H. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 2002; 51(4): 525-530.10.1002/ana.10163Search in Google Scholar

Hasegawa M, Smith MJ, Iijima M, Tabira T, Goedert M. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10. FEBS Lett 1999; 443(2): 93-96.10.1016/S0014-5793(98)01696-2Search in Google Scholar

Jiang Z, Cote J, Kwon JM, Goate AM, Wu JY. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17. Mol Cell Biol 2000; 20(11): 4036-4048.10.1128/MCB.20.11.4036-4048.20008577410805746Search in Google Scholar

Janssen JC, Warrington EK, Morris HR, Lantos P, Brown J, Revesz T, Wood N, Khan MN, Cipolotti L, Fox NC, Rossor MN. Clinical features of frontotemporal dementia due to the intronic tau 10(+16) mutation. Neurology 2002; 58(8): 1161-1168.10.1212/WNL.58.8.116111971081Search in Google Scholar

Hutton M. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms. Neurology 2001; 56(11 Suppl 4): S1-S25.10.1212/WNL.56.suppl_4.S2111402146Search in Google Scholar

Poorkaj P, Grossman M, Steinbart E, Payami H, Sdaovnick A, Nochlin D, Tabira T, Trojanowski JQ, Borson S, Galasko D, Reich S, Quinn B, Schellenberg G, Bird TD. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol 2001; 58(3): 383-387.10.1001/archneur.58.3.38311255441Search in Google Scholar

Grover A, Houlden H, Baker M, Adamson J, Lewis J, Prihar G, Pickering-Brown S, Duff K, Hutton M. 5' Splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10. J Biol Chem 1999; 274(21): 15134-15143.10.1074/jbc.274.21.1513410329720Search in Google Scholar

Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95(13): 7737-7741.10.1073/pnas.95.13.7737Search in Google Scholar

Varani L, Hasegawa M, Spillantini MG, Smith MJ, Murrell JR, Ghetti B, Klug A, Goedert M, Varani G. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc Natl Acad Sci USA 1999; 96(14): 8229-8234.10.1073/pnas.96.14.8229Search in Google Scholar

Spillantini MG, van Swieten JC, Goedert M,. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000; 2(4): 193-205.10.1007/s100489900084Search in Google Scholar

Yen S, Easson C, Nacharaju P, Hutton M, Yen SH. FTDP-17 tau mutations decrease the susceptibility of tau to calpain 1 digestion. FEBS Lett 1999; 461(1-2): 91-95.10.1016/S0014-5793(99)01427-1Search in Google Scholar

Chiti F, Stefani M, Taddei N, Ramponi G, Dobson CM. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 2003; 424(6950): 805-808.10.1038/nature0189112917692Search in Google Scholar

Molinuevo JL, Valldeoriola F, Alegret M, Oliva R, Tolosa E. Progressive supranuclear palsy: earlier age of onset in patients with the ô protein A0/A0 genotype. J Neurol 2000; 247(3): 206-208.10.1007/s00415005056410787116Search in Google Scholar

Stanford PM, Halliday GM, Brooks WS, Kwok JBJ, Storey CE, Creasey H, Morris JGL, Fulham MJ, Schofield PR. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene. Brain 2000; 123(5): 880-893.10.1093/brain/123.5.88010775534Search in Google Scholar

Rojo A, Pernaute RS, Fontan A, Ruiz PG, Honnorat J, Lynch T, Chin S, Gonzalo I, Rabano A, Martinez A, Daniel S, Pramsteller P, Morris H, Wood N, Lees A, Tabernero C, Nyggard T, Jackson AC, Hanson A, de Yébenes JG. Clinical genetics of familial progressive supranuclear palsy. Brain 1999; 122(7): 1233-1245.10.1093/brain/122.7.123310388790Search in Google Scholar

Higgins JJ, Rima L, Adler BA, Loveless JM. Mutational analysis of the tau gene in progressive supranuclear palsy. Neurology 1999; 2(7): 1421-1424.10.1212/WNL.53.7.142110534245Search in Google Scholar

Bergeron C, Davis A, Lang AE. Corticobasal ganglionic degeneration and progressive supranuclear palsy presenting with cognitive decline. Brain Pathol 1998; 8(2): 355-365.10.1111/j.1750-3639.1998.tb00159.x80983609546292Search in Google Scholar

Spillantini MG, Bird TD, Ghetti B. Fronto-temporal dementia and parkinsonism linked to chromosome 17: a new group of taupathies. Brain Pathol 1998; 8(2): 387-402.10.1111/j.1750-3639.1998.tb00162.xSearch in Google Scholar

Buée L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999; 9(4): 681-693.10.1111/j.1750-3639.1999.tb00550.xSearch in Google Scholar

Virginia M, Lee Y, Trojanowski JQ. Neurodegenerative tauopathies: human disease and transgenic mouse models. Neuron 1999; 24(3): 507-510.10.1016/S0896-6273(00)81106-XSearch in Google Scholar

Heutink P. Untangling tau-related dementia. Hum Mol Genet 2000; 9(6): 979-986.10.1093/hmg/9.6.97910767321Search in Google Scholar

Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 1995; 242(2): 99-104.10.1007/BF008878247707098Search in Google Scholar

Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Arch Neurol 1995; 52(4): 379-391.10.1001/archneur.1995.005402800650207710374Search in Google Scholar

Loftus SK, Morris JA, Carstea ED, Gu JZ, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld MA, Tagle DA, Pentchev PG, Pavan WJ. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 1997; 277(5323): 232-235.10.1126/science.277.5323.2329211850Search in Google Scholar

Love S, Bridges LR, Case CP. Neurofibrillary tangles in Niemann-Pick disease type C. Brain 1995; 118(1): 119-129.10.1093/brain/118.1.1197894998Search in Google Scholar

Auer IA, Schmidt ML, Lee VMY, Curry B, Suzuki K, Shin RW, Pentchev PG, Carstea ED, Trojanowski JQ. Paired helical filament tau (PHF-tau) in Niemann-Pick tytpe C disease is similar to PHF-tau in Alzheimer's disease. Acta Neuropathol 1995; 90(6): 547-551.10.1007/BF003185668615074Search in Google Scholar

Sergeant N, Delacourte A, Buée L. Tau protein as a differential biomarker of tauopathies. Biochim Biophys Acta 2005; 1739(2-3): 179-197.10.1016/j.bbadis.2004.06.02015615637Search in Google Scholar

Andreadis A, Wagner BK, Broderick JA, Kosik KS. A tau promoter region without neuronal specificity. J Neurochem 1996; 66(6): 2257-2263.10.1046/j.1471-4159.1996.66062257.xSearch in Google Scholar

Heicklen-Klein A, Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2. J Neurochem 2000; 75(4): 1408-1418.10.1046/j.1471-4159.2000.0751408.xSearch in Google Scholar

Andreadis A, Brown WM, Kosik KS. Structure and novel exons of the human tau gene. Biochemistry 1992; 31(43): 10626-10633.10.1021/bi00158a027Search in Google Scholar

Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 2004; 24(4): 277-295.10.1002/humu.20086Search in Google Scholar

Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA. Multiple isoforms of human micro-tubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989; 3(4): 519-526.10.1016/0896-6273(89)90210-9Search in Google Scholar

Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 1989; 8(2): 393-399.10.1002/j.1460-2075.1989.tb03390.xSearch in Google Scholar

Brandt R, Leger J, Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 1995; 131(5): 1327-1340.10.1083/jcb.131.5.1327Search in Google Scholar

Hirokawa N, Shiomura Y, Okabe S. Tau proteins: the molecular structure and mode of binding on microtubules. J Cell Biol 1988; 107(4): 1449-1459.10.1083/jcb.107.4.1449Search in Google Scholar

Buée L, Bussiére T, Buée-Scherrer V, Delacourte A, Hof PR. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev, 2000; 33(1): 95-130.10.1016/S0165-0173(00)00019-9Search in Google Scholar

Iqbal K, Alonso AC, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I. Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 2005; 1739(2-3): 198-210.10.1016/j.bbadis.2004.09.00815615638Search in Google Scholar

Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256(5054): 184-185.10.1126/science.1566067Search in Google Scholar

Buée-Scherrer V, Buée L, Leveugle D, Perl P, Vermesch P, Hof PR, Delacourte A. Pathological tau proteins in postencephalitic parkinsonism: comparison with Alzheimer's disease and other neurodegenerative disorders. Ann Neurol 1997; 42(3): 356-359.10.1002/ana.410420312Search in Google Scholar

Tolnay M, Probst A. The neuropathological spectrum of neurodegenerative tauopathies. Int Union Biochem Mol Biol Life 2003; 55(6): 299-305.10.1080/1521654032000114348Search in Google Scholar

Albers DS, Augood SJ. New insights into progressive supranuclear palsy. Trends Neurosci 2001; 24(6): 347-352.10.1016/S0166-2236(00)01794-XSearch in Google Scholar

ISSN:
1311-0160
Langue:
Anglais
Périodicité:
2 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other